HK1014862A1 - Method for inducing humoral and cellular immune responses utilizing intracellular delivery of peptide-coated microparticles - Google Patents

Method for inducing humoral and cellular immune responses utilizing intracellular delivery of peptide-coated microparticles

Info

Publication number
HK1014862A1
HK1014862A1 HK98119179A HK98119179A HK1014862A1 HK 1014862 A1 HK1014862 A1 HK 1014862A1 HK 98119179 A HK98119179 A HK 98119179A HK 98119179 A HK98119179 A HK 98119179A HK 1014862 A1 HK1014862 A1 HK 1014862A1
Authority
HK
Hong Kong
Prior art keywords
peptide
immune responses
cellular immune
intracellular delivery
coated microparticles
Prior art date
Application number
HK98119179A
Other languages
English (en)
Inventor
Edward C Pohlmann
Michael J Sheehy
Kenneth A Barton
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of HK1014862A1 publication Critical patent/HK1014862A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HK98119179A 1994-11-15 1998-12-29 Method for inducing humoral and cellular immune responses utilizing intracellular delivery of peptide-coated microparticles HK1014862A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34778594A 1994-11-15 1994-11-15
PCT/US1995/014698 WO1996014855A1 (fr) 1994-11-15 1995-11-13 Procede destine a induire des reponses immunitaires humorales et cellulaires par apport intracellulaire de microparticules a enrobage peptidique

Publications (1)

Publication Number Publication Date
HK1014862A1 true HK1014862A1 (en) 1999-10-08

Family

ID=23365269

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98119179A HK1014862A1 (en) 1994-11-15 1998-12-29 Method for inducing humoral and cellular immune responses utilizing intracellular delivery of peptide-coated microparticles

Country Status (5)

Country Link
US (1) US20050025777A1 (fr)
EP (1) EP0850069B1 (fr)
DE (1) DE69526260T2 (fr)
HK (1) HK1014862A1 (fr)
WO (1) WO1996014855A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
DE19648656B4 (de) * 1996-11-14 2005-08-11 Hiper Ceramics Gmbh Vorrichtung zum Beschleunigen von Partikeln auf Zellen zum ballistischen Transfer
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
WO2000047227A2 (fr) 1999-02-09 2000-08-17 Powderject Vaccines, Inc. IMMUNISATION CONTRE $i(MYCOBACTERIUM TUBERCULOSIS)
CA2389680A1 (fr) * 1999-11-03 2001-05-10 Powderject Vaccines, Inc. Composition vaccinale a base d'acides nucleiques comportant un promoteur de gene cd80/cd86 mammalien suscitant une expression antigenique
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
AUPR011700A0 (en) 2000-09-14 2000-10-05 Austin Research Institute, The Composition comprising immunogenic virus sized particles (VSP)
CA2447616A1 (fr) * 2001-05-18 2002-11-28 Deborah Fuller Composition de vaccin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100792A (en) * 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5120657A (en) * 1986-12-05 1992-06-09 Agracetus, Inc. Apparatus for genetic transformation
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus

Also Published As

Publication number Publication date
EP0850069A1 (fr) 1998-07-01
DE69526260T2 (de) 2002-10-17
EP0850069A4 (fr) 1999-02-03
EP0850069B1 (fr) 2002-04-03
WO1996014855A1 (fr) 1996-05-23
DE69526260D1 (de) 2002-05-08
US20050025777A1 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
US5584086B1 (en) Therapeutic pillow and method
ZA967758B (en) Therapeutic and prophylactic methods using heat shock proteins
ZA90171B (en) Treatment methods and vaccines for stimulating an immune response
EP0851765A4 (fr) Procedes therapeutique et profilactique utilisant des proteines du choque thermique
ZA908693B (en) Encapsulated sweetener-flavor delivery system and method of preparation
IL108079A0 (en) Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
PL331285A1 (en) Erythromycins and method of preparing them
HUP9903537A3 (en) Compositions comprising microparticles of water-insoluble substances and method for preparing same
EP0716840A3 (fr) Cage de fusion conique, et méthode pour son implantation
PL309972A1 (en) Synthetic stimulating amino acids and methods of obtaining them
EP1003450A4 (fr) Procede et appareil pour provoquer l'hypothermie
CS33491A2 (en) Block copolymers from ionic catalysis and method of their preparation
PL284935A1 (en) Method of aminating carbonitriles and iminonitriles
HUP0200421A3 (en) Liposomes of controlled size and method for their preparation
EP0693931A4 (fr) Proteines et peptides immunogenes du cancer et procede d'utilisation
HU9601908D0 (en) T cell antigen receptor v region proteins and methods of preparation thereof
PL326756A1 (en) Anticarcinogenic vaccine and method of obtaining same
HK1014862A1 (en) Method for inducing humoral and cellular immune responses utilizing intracellular delivery of peptide-coated microparticles
SG74075A1 (en) Baggage pusher device system and method of use
EP0487060A3 (en) Polygon division method and apparatus
ZA906400B (en) Encapsulated flavor delivery system and method of preparation
NZ215023A (en) Vaccine against plasmodium falciparum and antigenic peptides
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
EP0956046A4 (fr) Vaccins cellulaires immunotherapeutiques et leurs procedes de preparation
EP0453497A4 (en) Treatment methods and vaccines

Legal Events

Date Code Title Description
PF Patent in force